Life Sciences Tools and Services
Company Overview of Ngen, Inc.
Ngen, Inc., a diagnostics company, develops, manufactures, and sells diagnostic products for use in the in vitro diagnostic market in the United States, Canada, and Europe. It offers diagnostic test kits and reagents based on polymerase chain reaction (PCR) technology in the molecular diagnostic market. The company’s PCR molecular product lines comprise Q-PCR Alert products for in-vitro diagnostic use, and are sold in Italy via a contract sales force and in other European countries through a network of distributors; and MGB Alert products. It also offers point-of-care products, which include qualitative cardiac test products that are rapid test assays used in emergency care settings for the ...
10398 Pacific Center Court
San Diego, CA 92121
Founded in 1993
Key Executives for Ngen, Inc.
Ngen, Inc. does not have any Key Executives recorded.
Ngen, Inc. Key Developments
SEC Revokes Registration Of Registered Securities Of Nanogen
Mar 20 14
An Administrative Law Judge has issued an Initial Decision of Default as to Nanogen, Inc.. The Initial Decision found that the company was issuer of securities registered pursuant to Section 12(g) of the Securities Exchange Act of 1934 (Exchange Act), and the company failed to comply with Section 13(a) of the Exchange Act and Exchange Act Rules 13a-1 and/or 13a-13 by not filing required periodic reports with the Securities and Exchange Commission (SEC). The Initial Decision finds these allegations to be true and revokes the registration of each class of the company’s registered securities, pursuant to Section 12(j) of the Securities Exchange Act of 1934.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries